Demyelinating Disease following Anti-TNFa Treatment: A Causal or Coincidental Association? Report of Four Cases and Review of the Literature

Tumor necrosis factor antagonists (anti-TNFa) are an established therapeutic option for several autoimmune and inflammatory bowel diseases. Despite their clinical effectiveness, neurological adverse events have been reported and literature data suggest a potential role of anti-TNFa in the induction...

Descripción completa

Detalles Bibliográficos
Autores principales: Andreadou, E., Kemanetzoglou, E., Brokalaki, Ch., Evangelopoulos, M. E., Kilidireas, C., Rombos, A., Stamboulis, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3670521/
https://www.ncbi.nlm.nih.gov/pubmed/23762678
http://dx.doi.org/10.1155/2013/671935

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3670521/
https://www.ncbi.nlm.nih.gov/pubmed/23762678
http://dx.doi.org/10.1155/2013/671935

Ejemplares similares